Dr Matthew J. Killeen

Multiple lines of converging evidence link polyphenols, particularly hydroxytyrosol and HIDROXTM, to improved clinical outcomes. In human and animal studies, hydroxytyrosol and HIDROXTM have been shown to induce significant therapeutic effects on the cardiovascular system, improve the quality of life of patients with osteoporosis, and reduce markers of inflammation. These findings have all been reported in peerreviewed, internationally-recognised academic journals. Hydroxytyrosol is well absorbed following oral administration, and rapidly reaches high levels in the blood. Hydroxytyrosol and HIDROXTM have strong safety profiles and are not associated with major adverse events. Patients receiving HIDROXTM are likely to have a strong level of adherence to the supplement.